Clinical Trial Update: Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a venetoclax-based combination with azacitidine, chidamide, vindesine, and dexamethasone in newly diagnosed adult T-cell leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• DEXAMETHASONE (Dexamethasone)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)
• Vindesine (vindesine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Adult T-cell Leukemia/Lymphoma | Phase 2 | Status: RECRUITING